The Effect of Microbiota on Colon Carcinogenesis (original) (raw)

1. Ferlay, J, Soerjomataram, I, Dikshit, R, Eser, S, Mathers, C, and Rebelo, M (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136, E359-86.
   
2. Aran, V, Victorino, AP, Thuler, LC, and Ferreira, CG (2016). Colorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset and mortality. Clin Colorectal Cancer. 15, 195-203.
   
3. Thursby, E, and Juge, N (2017). Introduction to the human gut microbiota. Biochem J. 474, 1823-36.
   
4. Hooper, LV, Littman, DR, and Macpherson, AJ (2012). Interactions between the microbiota and the immune system. Science. 336, 1268-73.
   
5. Gill, SR, Pop, M, DeBoy, RT, Eckburg, PB, Turnbaugh, PJ, and Samuel, BS (2006). Metagenomic analysis of the human distal gut microbiome. Science. 312, 1355-9.
   
6. Sender, R, Fuchs, S, and Milo, R (2016). Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14, e1002533.
   
7. Egert, M, De Graaf, AA, Smidt, H, de Vos, WM, and Venema, K (2006). Beyond diversity: functional microbiomics of the human colon. Trends Microbiol. 14, 86-91.
   
8. Possemiers, S, Bolca, S, Verstraete, W, and Heyerick, A (2011). The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals. Fitoterapia. 82, 53-66.
   
9. Dulal, S, and Keku, TO (2014). Gut microbiome and colorectal adenomas. Cancer J. 20, 225-31.
   
10. Fearon, ER, and Vogelstein, B (1990). A genetic model for colorectal tumorigenesis. Cell. 61, 759-67.
    
11. Levy, M, Thaiss, CA, and Elinav, E (2014). The microbiota: a new player in the etiology of colorectal cancer. Curr Colorectal Cancer Rep. 10, 1-8.
    
12. Rowland, IR (2009). The role of the gastrointestinal microbiota in colorectal cancer. Curr Pharm Des. 15, 1524-7.
    
13. Marchesi, JR, Dutilh, BE, Hall, N, Peters, WH, Roelofs, R, and Boleij, A (2011). Towards the human colorectal cancer microbiome. PLoS One. 6, e20447.
    
14. Richard, ML, Liguori, G, Lamas, B, Brandi, G, da Costa, G, and Hoffmann, TW (2018). Mucosa-associated microbiota dysbiosis in colitis associated cancer. Gut Microbes. 4, 131-42.
    
15. Sun, J, and Kato, I (2016). Gut microbiota, inflammation and colorectal cancer. Genes Dis. 3, 130-43.
    
16. Johansson, ME, Phillipson, M, Petersson, J, Velcich, A, Holm, L, and Hansson, GC (2008). The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A. 105, 15064-9.
    
17. Kelsall, B (2008). Recent progress in understanding the phenotype and function of intestinal dendritic cells and macrophages. Mucosal Immunol. 1, 460-9.
    
18. Tlaskalová-Hogenová, H, Stepánková, R, Hudcovic, T, Tucková, L, Cukrowska, B, and Lodinová-Zádníková, R (2004). Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett. 93, 97-108.
    
19. Vannucci, L, Stepankova, R, Kozakova, H, Fiserova, A, Rossmann, P, and Tlaskalova-Hogenova, H (2008). Colorectal carcinogenesis in germ-free and conventionally reared rats: different intestinal environments affect the systemic immunity. Int J Oncol. 32, 609-17.
    
20. Akira, S, and Hemmi, H (2003). Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett. 85, 85-95.
    
21. Bland, PW (1998). Mucosal T cell-epithelial cell interactions, mucosal T cells. New York: Karger Publishers, pp. 40-63
22. Donaldson, GP, Ladinsky, MS, Yu, KB, Sanders, JG, Yoo, BB, and Chou, WC (2018). Gut microbiota utilize immunoglobulin A for mucosal colonization. Science. 360, 795-800.
    
23. Cebra, JJ (1999). Influences of microbiota on intestinal immune system development. Am J Clin Nutr. 69, 1046s-51s.
    
24. Reddy, BS, Narisawa, T, Maronpot, R, Weisburger, JH, and Wynder, EL (1975). Animal models for the study of dietary factors and cancer of the large bowel. Cancer Res. 35, 3421-6.
    
25. Funabashi, H, Uchida, K, Kado, S, Matsuoka, Y, and Ohwaki, M (2001). Establishment of a Tcrb and Trp53 genes deficient mouse strain as an animal model for spontaneous colorectal cancer. Exp Anim. 50, 41-7.
    
26. Kado, S, Uchida, K, Funabashi, H, Iwata, S, Nagata, Y, and Ando, M (2001). Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer Res. 61, 2395-8.
    
27. Dove, WF, Clipson, L, Gould, KA, Luongo, C, Marshall, DJ, and Moser, AR (1997). Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res. 57, 812-4.
    
28. Tomkovich, S, Yang, Y, Winglee, K, Gauthier, J, Mühlbauer, M, and Sun, X (2017). Locoregional effects of microbiota in a preclinical model of colon carcinogenesis. Cancer Res. 77, 2620-32.
    
29. Louis, P, Hold, GL, and Flint, HJ (2014). The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 12, 661-72.
    
30. Ou, J, Carbonero, F, Zoetendal, EG, DeLany, JP, Wang, M, and Newton, K (2013). Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr. 98, 111-20.
    
31. Brownawell, AM, Caers, W, Gibson, GR, Kendall, CW, Lewis, KD, and Ringel, Y (2012). Prebiotics and the health benefits of fiber: current regulatory status, future research, and goals. J Nutr. 142, 962-74.
    
32. Rivière, A, Selak, M, Lantin, D, Leroy, F, and De Vuyst, L (2016). Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol. 7, 979.
    
33. Encarnação, J, Abrantes, AM, Pires, AS, and Botelho, MF (2015). Revisit dietary fiber on colorectal cancer: butyrate and its role on prevention and treatment. Cancer Metastasis Rev. 34, 465-78.
    
34. Chen, J, and Vitetta, L (2018). Inflammation-modulating effect of butyrate in the prevention of colon cancer by dietary fiber. Clin Colorectal Cancer. 17, e541-4.
    
35. Donohoe, DR, Collins, LB, Wali, A, Bigler, R, Sun, W, and Bultman, SJ (2012). The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell. 48, 612-26.
    
36. Wu, X, Wu, Y, He, L, Wu, L, Wang, X, and Liu, Z (2018). Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer. J Cancer. 9, 2510-7.
    
37. Humphreys, KJ, Conlon, MA, Young, GP, Topping, DL, Hu, Y, and Winter, JM (2014). Dietary manipulation of oncogenic microRNA expression in human rectal mucosa: a randomized trial. Cancer Prev Res (Phila). 7, 786-95.
    
38. Furusawa, Y, Obata, Y, Fukuda, S, Endo, TA, Nakato, G, and Takahashi, D (2013). Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 504, 446-50.
    
39. Conlon, MA, Bird, AR, Clarke, JM, Le Leu, RK, Christophersen, CT, and Lockett, TJ (2015). Lowering of large bowel butyrate levels in healthy populations is unlikely to be beneficial. J Nutri. 145, 1030-1.
    
40. Singh, N, Gurav, A, Sivaprakasam, S, Brady, E, Padia, R, and Shi, H (2014). Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 40, 128-39.
    
41. Van den Abbeele, P, Belzer, C, Goossens, M, Kleerebezem, M, De Vos, WM, and Thas, O (2013). Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J. 7, 949-61.
    
42. Velasquez-Manoff, M (2015). Gut microbiome: the peacekeepers. Nature. 518, S3-11.
    
43. Wu, N, Yang, X, Zhang, R, Li, J, Xiao, X, and Hu, Y (2013). Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol. 66, 462-70.
    
44. Whitehead, RH, Young, GP, and Bhathal, PS (1986). Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). Gut. 27, 1457-63.
    
45. Freeman, HJ (1986). Effects of differing concentrations of sodium butyrate on 1,2-dimethylhydrazine-induced rat intestinal neoplasia. Gastroenterology. 91, 596-602.
    
46. Deschner, EE, Ruperto, JF, Lupton, JR, and Newmark, HL (1990). Dietary butyrate (tributyrin) does not enhance AOM-induced colon tumorigenesis. Cancer Lett. 52, 79-82.
    
47. Archer, SY, Meng, S, Shei, A, and Hodin, RA (1998). p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci U S A. 95, 6791-6.
    
48. O'Keefe, SJ, Ou, J, Aufreiter, S, O'Connor, D, Sharma, S, and Sepulveda, J (2009). Products of the colonic microbiota mediate the effects of diet on colon cancer risk. J Nutr. 139, 2044-8.
    
49. Donohoe, DR, Garge, N, Zhang, X, Sun, W, O'Connell, TM, and Bunger, MK (2011). The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 13, 517-26.
    
50. Belcheva, A, Irrazabal, T, Robertson, SJ, Streutker, C, Maughan, H, and Rubino, S (2014). Gut microbial metabolism drives transformation of Msh2-deficient colon epithelial cells. Cell. 158, 288-99.
    
51. Teixeira, TF, Grześkowiak, Ł, Franceschini, SC, Bressan, J, Ferreira, CL, and Peluzio, MC (2013). Higher level of faecal SCFA in women correlates with metabolic syndrome risk factors. Br J Nutr. 109, 914-9.
    
52. Payne, AN, Chassard, C, Zimmermann, M, Müller, P, Stinca, S, and Lacroix, C (2011). The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutr Diabetes. 1, e12.
    
53. Lupton, JR (2004). Microbial degradation products influence colon cancer risk: the butyrate controversy. J Nutr. 134, 479-82.
    
54. Zeng, H, Lazarova, DL, and Bordonaro, M (2014). Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention. World J Gastrointest Oncol. 6, 41-51.
    
55. Ferrario, C, Taverniti, V, Milani, C, Fiore, W, Laureati, M, and De Noni, I (2014). Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults. J Nutr. 144, 1787-96.
    
56. Kim, DH, and Jin, YH (2001). Intestinal bacterial beta-glucuronidase activity of patients with colon cancer. Arc Pharm Res. 24, 564-7.
    
57. Liong, MT (2008). Roles of probiotics and prebiotics in colon cancer prevention: postulated mechanisms and in-vivo evidence. Int J Mol Sci. 9, 854-63.
    
58. Kulkarni, N, and Reddy, BS (1994). Inhibitory effect of Bifidobacterium lon-gum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial beta-glucuronidase. Proc Soc Exp Biol Med. 207, 278-83.
    
59. Rowland, I, Granli, T, Bøckman, OC, Key, PE, and Massey, RC (1991). Endogenous N-nitrosation in man assessed by measurement of apparent total N-nitroso compounds in faeces. Carcinogenesis. 12, 1395-401.
    
60. Rowland, RHIR (2000). Metabolic activities of the gut microflora in relation to cancer. Microb Ecol Health Dis. 12, 179-85.
    
61. Kobayashi, J (2018). Effect of diet and gut environment on the gastrointestinal formation of N-nitroso compounds: a review. Nitric Oxide. 73, 66-73.
    
62. Massey, RC, Key, PE, Mallett, AK, and Rowland, IR (1988). An investigation of the endogenous formation of apparent total N-nitroso compounds in conventional microflora and germ-free rats. Food Chem Toxicol. 26, 595-600.
    
63. Ijssennagger, N, Derrien, M, van Doorn, GM, Rijnierse, A, van den Bogert, B, and Müller, M (2012). Dietary heme alters microbiota and mucosa of mouse colon without functional changes in host-microbe cross-talk. PLoS One. 7, e49868.
    
64. Gamage, SMK, Dissabandara, L, Lam, AK, and Gopalan, V (2018). The role of heme iron molecules derived from red and processed meat in the pathogenesis of colorectal carcinoma. Crit Rev Oncol Hematol. 126, 121-8.
    
65. Ijssennagger, N, Belzer, C, Hooiveld, GJ, Dekker, J, van Mil, SW, and Müller, M (2015). Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc Natl Acad Sci U S A. 112, 10038-43.
    
66. Constante, M, Fragoso, G, Calvé, A, Samba-Mondonga, M, and Santos, MM (2017). Dietary heme induces gut dysbiosis, aggravates colitis, and potentiates the development of adenomas in mice. Front Microbiol. 8, 1809.
    
67. David, LA, Maurice, CF, Carmody, RN, Gootenberg, DB, Button, JE, and Wolfe, BE (2013). Diet rapidly and reproducibly alters the human gut microbiome. Nature. 505, 559-63.
    
68. Barrasa, JI, Olmo, N, Lizarbe, MA, and Turnay, J (2013). Bile acids in the colon, from healthy to cytotoxic molecules. Toxicol In Vitro. 27, 964-77.
    
69. Jones, BV, Begley, M, Hill, C, Gahan, CG, and Marchesi, JR (2008). Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci U S A. 105, 13580-5.
    
70. Nagengast, FM, Grubben, MJ, and van Munster, IP (1995). Role of bile acids in colorectal carcinogenesis. Eur J Cancer. 31, 1067-70.
    
71. Rafter, JJ, Eng, VW, Furrer, R, Medline, A, and Bruce, WR (1986). Effects of calcium and pH on the mucosal damage produced by deoxycholic acid in the rat colon. Gut. 27, 1320-9.
    
72. Payne, CM, Bernstein, H, Bernstein, C, and Garewal, H (1995). Role of apoptosis in biology and pathology: resistance to apoptosis in colon carcinogenesis. Ultrastruct Pathol. 19, 221-48.
    
73. Powell, AA, Akare, S, Qi, W, Herzer, P, Jean-Louis, S, and Feldman, RA (2006). Resistance to ursodeoxycholic acid-induced growth arrest can also result in resistance to deoxycholic acid-induced apoptosis and increased tumorgenicity. BMC Cancer. 6, 219.
    
74. Czerucka, D, Piche, T, and Rampal, P (2007). Review article: yeast as probiotics --saccharomyces boulardii. Aliment Pharmacol Ther. 26, 767-78.
    
75. Claesson, MJ, Cusack, S, O'Sullivan, O, Greene-Diniz, R, de Weerd, H, and Flannery, E (2011). Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A. 108, 4586-91.
    
76. Biagi, E, Nylund, L, Candela, M, Ostan, R, Bucci, L, and Pini, E (2010). Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PloS One. 5, e10667.
    
77. Franceschi, C, Bonafè, M, Valensin, S, Olivieri, F, De Luca, M, and Ottaviani, E (2000). Inflamm–aging: an evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 908, 244-54.
    
78. Lee, SM, Kim, N, Park, JH, Nam, RH, Yoon, K, and Lee, DH (2018). Comparative analysis of ileal and cecal microbiota in aged rats. J Cancer Prev. 23, 70-6.
    
79. Lee, SM, Kim, N, Yoon, H, Nam, RH, and Lee, DH (2018). Microbial changes and host response in F344 rat colon depending on sex and age following a high-fat diet. Front Microbiol. 9, 2236.